RSS

dengue

Sanofi is requesting that health authorities update information on its dengue vaccine Dengvaxia, as a result of a new analysis of long-term clinical trial data, which found differences in vaccine performance based on prior dengue infection. more

News

A once abandoned drug could be used to fight Ebola, Zika and dengue viruses, according to scientists from Stanford University more

News

Sanofi Pasteur, the vaccines division of Sanofi, has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease more

News

Mexican authorities have granted marketing authorisation to Sanofi Pasteur’s Dengvaxia, making it the first vaccine to be licensed for the prevention of dengue more

News